AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2014

Aug 4, 2014

5229_dirs_2014-08-04_53dd4225-571a-47b9-ba8e-5ec419c9dc3c.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1650O

AstraZeneca PLC

04 August 2014

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 1 August 2014, Bruce Burlington, a Director of the Company notified us that, on 1 August 2014, he purchased 500 AstraZeneca American Depositary Shares (ADSs) at a price of $72.71 per ADS.

One AstraZeneca ADS equals one AstraZeneca PLC Ordinary Share of $0.25.

A C N Kemp

Company Secretary

4 August 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUSORRSRAWRAR